Evidence map›Paper›PMID 24240189›Full record

ArticleCell cycle (Georgetown, Tex.)2014

Direct BMP2/4 signaling through BMP receptor IA regulates fetal thymocyte progenitor homeostasis and differentiation to CD4+CD8+ double-positive cell.

Ariadne L Hager-Theodorides, Susan E Ross, Hemant Sahni, Yuji Mishina, Anna L Furmanski, Tessa Crompton

Open access · hybridAbstract read
In one paragraph

Article in Cell cycle (Georgetown, Tex.), 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
1.5field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 27 citations in OpenAlex.

  1. Article
  2. Bone Morphogenetic Proteins Shape TFrontiers in immunology · 2022
    Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Review
  12. Hedgehog Signalling in the Embryonic Mouse Thymus.Journal of developmental biology · 2016
    Article
  13. Article
  14. Article
  15. Review
  16. Review
  17. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 4 countries.

Ariadne L Hager-TheodoridesDepartment of Animal Science and Aquaculture; Laboratory of Animal Breeding and Husbandry; Agricultural University of Athens; Athens, Greece.
Susan E RossImmunobiology Unit; UCL Institute of Child Health; London, UK.
Hemant SahniImmunobiology Unit; UCL Institute of Child Health; London, UK.
Yuji MishinaUniversity of Michigan; School of Dentistry; Department of Biologic and Materials Sciences; Ann Arbor, MI USA.
Anna L FurmanskiImmunobiology Unit; UCL Institute of Child Health; London, UK.
Tessa CromptonImmunobiology Unit; UCL Institute of Child Health; London, UK.
Institute of Child Health · INAgricultural University of Athens · GRAnn Arbor Center for Independent Living · USUniversity College London · GB

Funding

Biotechnology and Biological Sciences Research Council BB/H005188/1Medical Research Council G0900161Wellcome Trust
6 · The paper itself

Abstract

BMP2/4 signaling is required for embryogenesis and involved in thymus morphogenesis and T-lineage differentiation. In vitro experiments have shown that treatment of thymus explants with exogenous BMP4 negatively regulated differentiation of early thymocyte progenitors and the transition from CD4-CD8- (DN) to CD4+CD8+ (DP). Here we show that in vivo BMP2/4 signaling is required for fetal thymocyte progenitor homeostasis and expansion, but negatively regulates differentiation from DN to DP cell. Unexpectedly, conditional deletion of BMPRIA from fetal thymocytes (using the Cre-loxP system and directing excision to hematopoietic lineage cells with the Vav promoter) demonstrated that physiological levels of BMP2/4 signaling directly to thymocytes through BMPRIA are required for normal differentiation and expansion of early fetal DN thymocytes. In contrast, the arrest in early thymocyte progenitor differentiation caused by exogenous BMP4 treatment of thymus explants is induced in part by direct signaling to thymocytes through BMPRIA, and in part by indirect signaling through non-hematopoietic cells. Analysis of the transition from fetal DN to DP cell, both by ex vivo analysis of conditional BMPRIA-deficient thymocytes and by treatment of thymus explants with the BMP4-inhibitor Noggin demonstrated that BMP2/4 signaling is a negative regulator at this stage. We showed that at this stage of fetal T-cell development BMP2/4 signals directly to thymocytes through BMPRIA.

Indexed as

AnimalsBone Morphogenetic Protein 2Bone Morphogenetic Protein 4Bone Morphogenetic Protein Receptors, Type ICD4 AntigensCD8 AntigensCell DifferentiationFetusHematopoietic Stem CellsHomeostasisHumansMiceMice, Inbred C57BLMice, KnockoutSignal TransductionThymus GlandBone Morphogenetic Protein 2Bone Morphogenetic Protein 4Bone Morphogenetic Protein Receptors, Type ICD4 AntigensCD8 AntigensAlk3BMP2/4BMPRIAdifferentiationDN thymocyteDPNogginSmadT-cell developmentthymus

Identifiers

PMID24240189
PMCPMC3906248
OpenAlexW1983795407

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.